Rubis (RBSFY)
USD 5.94
(0.0%)
USD 5.94
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 562.61 Million | 420.95 Million | 294.65 Million | 590.98 Million | 497.91 Million | 325.48 Million |
| Net Income | 353.69 Million | 271.9 Million | 304.73 Million | 195.52 Million | 294.46 Million | 270.78 Million |
| Depreciation & Amortization | 222.14 Million | 100.92 Million | 163.2 Million | 189.1 Million | 198.12 Million | 116.55 Million |
| Deferred income taxes | - | -21.3 Million | -4.38 Million | - | - | - |
| Stock-based compensation | - | 21.3 Million | 4.38 Million | - | - | - |
| Change in working capital | -148.15 Million | -31.35 Million | -214.45 Million | 132.23 Million | -78.09 Million | -79.49 Million |
| Other non-cash items | 134.93 Million | 79.48 Million | 41.17 Million | 74.13 Million | 83.41 Million | 17.64 Million |
| Investing Cash Flow | -313.05 Million | -501.12 Million | -258.98 Million | 3.86 Million | -560.88 Million | -296.21 Million |
| Investments in PPE | -283.34 Million | -258.41 Million | -205.68 Million | -245.39 Million | -229.77 Million | -232.77 Million |
| Acquisitions | -11.93 Million | 57.03 Million | 8.73 Million | -96.26 Million | 71.1 Million | 4.31 Million |
| Investment purchases | -12.13 Million | -343.9 Million | -84.14 Million | -18.1 Million | -403.25 Million | -76.61 Million |
| Sales/Maturities of investments | - | - | 3.46 Million | 183.87 Million | -71.1 Million | 4.54 Million |
| Other Investing Activities | -17.77 Million | 44.16 Million | 18.64 Million | 179.75 Million | 72.14 Million | 4.31 Million |
| Financing Cash Flow | -394.61 Million | 24.91 Million | -251.18 Million | -372.6 Million | 203.51 Million | -102.95 Million |
| Debt repayment | -100.41 Million | -847.81 Million | -677.27 Million | -398.77 Million | -335.54 Million | -356.11 Million |
| Dividends payments | -197.52 Million | -191.06 Million | -83.57 Million | -197.96 Million | -154.52 Million | -169.26 Million |
| Common Stock Repurchased | -36.51 Million | -46 Thousand | -153.16 Million | -925 Thousand | 557.98 Million | -798 Thousand |
| Common Stock Issuance | 4.72 Million | 3.4 Million | 7.08 Million | 118.48 Million | 134.61 Million | 158.78 Million |
| Other Financing Activities | -96.67 Million | 1.06 Billion | 655.75 Million | 106.57 Million | 972 Thousand | 264.44 Million |
| Accounts receivables | -68.25 Million | -142.68 Million | -150.96 Million | 133.14 Million | -51.89 Million | -75.08 Million |
| Accounts payables | 56.47 Million | 188.67 Million | 141.78 Million | -189.7 Million | 26.1 Million | 54.97 Million |
| Inventory | -79.89 Million | -77.34 Million | -205.28 Million | 188.79 Million | -52.3 Million | -59.37 Million |
| Other working capital | - | - | - | 1.00 | -78.09 Million | -20.11 Million |
| Cash at beginning of period | 804.9 Million | 874.89 Million | 1.08 Billion | 860.15 Million | 755.96 Million | 825.3 Million |
| Cash at end of period | 589.68 Million | 804.9 Million | 874.89 Million | 1.08 Billion | 860.15 Million | 755.96 Million |
| Capital Expenditure | -283.34 Million | -258.41 Million | -205.68 Million | -245.39 Million | -229.77 Million | -232.77 Million |
| Effect of forex changes on cash | -70.17 Million | -14.73 Million | 8.81 Million | -35.12 Million | -2.04 Million | 4.34 Million |
| Net cash flow / Change in cash | -215.22 Million | -69.98 Million | -206.69 Million | 221.43 Million | 104.18 Million | -69.33 Million |
| Free Cash Flow | 279.27 Million | 162.54 Million | 88.97 Million | 345.59 Million | 268.14 Million | 92.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 64.75 Million | 64.75 Million | 353.69 Million | 183.07 Million | 91.53 Million | 170.62 Million |
| Depreciation & Amortization | 51.63 Million | 51.63 Million | 187.99 Million | 101.93 Million | 66.62 Million | 87.52 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -25.65 Million | -25.65 Million | -91.68 Million | -43.68 Million | -80.84 Million | -48 Million |
| Other non-cash items | 52.07 Million | 52.07 Million | 505.1 Million | 281.32 Million | 83.39 Million | 225.24 Million |
| Investing Cash Flow | -55.52 Million | -55.52 Million | -319.16 Million | -157.64 Million | -78.71 Million | -161.51 Million |
| Investments in PPE | -51.58 Million | -51.58 Million | -283.34 Million | -151.37 Million | -75.68 Million | -131.97 Million |
| Acquisitions | -6.56 Million | -6.56 Million | 6.56 Million | 1.42 Million | -5.96 Million | 5.13 Million |
| Investment purchases | -13.26 Million | - | -12.13 Million | -6.8 Million | - | -5.33 Million |
| Sales/Maturities of investments | - | - | - | -1.00 | - | - |
| Other Investing Activities | 2.62 Million | 2.62 Million | -30.25 Million | -899.99 Thousand | 2.93 Million | -29.35 Million |
| Financing Cash Flow | -154.24 Million | -154.24 Million | -313.33 Million | -109.84 Million | -78.17 Million | -203.48 Million |
| Debt repayment | -35.78 Million | - | -63.9 Million | -88.65 Million | - | -24.75 Million |
| Dividends payments | -102.48 Million | -102.48 Million | -197.52 Million | - | - | -197.52 Million |
| Common Stock Repurchased | -543.5 Thousand | -543.5 Thousand | -36.51 Million | 384 Thousand | - | -384 Thousand |
| Common Stock Issuance | 8.85 Million | - | 4.72 Million | 614 Thousand | - | 4.11 Million |
| Other Financing Activities | -51.2 Million | -51.2 Million | -20.11 Million | -3.6 Million | -78.17 Million | -16.5 Million |
| Accounts receivables | -2.62 Million | -2.62 Million | -68.25 Million | -71.27 Million | -35.63 Million | 3.01 Million |
| Accounts payables | 25.41 Million | - | 56.47 Million | 118.01 Million | - | -61.54 Million |
| Inventory | -23.03 Million | -23.03 Million | -79.89 Million | -90.42 Million | -45.21 Million | 10.52 Million |
| Other working capital | - | - | - | 37.16 Million | - | -54.77 Million |
| Cash at beginning of period | 589.68 Million | - | 804.9 Million | 614.28 Million | - | 804.9 Million |
| Cash at end of period | 457.71 Million | -65.98 Million | 589.68 Million | 589.68 Million | -12.3 Million | 614.28 Million |
| Capital Expenditure | -51.58 Million | -51.58 Million | -283.34 Million | -151.37 Million | -75.68 Million | -131.97 Million |
| Effect of forex changes on cash | 966 Thousand | 966 Thousand | -70.17 Million | -16.1 Million | -16.1 Million | -18.97 Million |
| Net cash flow / Change in cash | -131.97 Million | -65.98 Million | -215.22 Million | -24.6 Million | -12.3 Million | -190.61 Million |
| Free Cash Flow | 91.22 Million | 91.22 Million | 204.1 Million | 123.73 Million | 85.01 Million | 80.37 Million |
MPP
3624
MEDICO
FOSUF
603939
NESN